Schedule 13G ownership disclosure

INOTEK PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 45780V102

Event date: 2016-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,366,500
Percent of class
5.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-17-000013
Form type
SC 13G
Filer
GREAT POINT PARTNERS LLC
CIK
CIK 1281446
Filed
Jan 03, 2017
Reporting period
Dec 21, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub